Belimumab in Patients with Chronic Lymphocytic Leukemia
Belimumab in Patients with Chronic Lymphocytic Leukemia
Active, not recruiting · NCT05069051 · Registry updated 2024-12-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Belimumab in Patients with Chronic Lymphocytic Leukemia | Chronic Lymphoid Leukemia in Relapse | Active, not recruiting | Phase 2 | 2024-12-09 | NCT05069051 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
| University Hospital Tuebingen | 123 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Tuebingen, CCU Translational Immunology | Tübingen | Germany | 1 |